TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it has been deemed in compliance with the Nasdaq Hearings Panel’s decision dated August 6, 2008 and that accordingly, the Panel has determined to continue the listing of EpiCept’s securities on The Nasdaq Stock Market.
